| Today's Open | $1.10 |
|---|---|
| Previous Close | $1.12 |
| Daily Range | $1.09 - $1.13 |
| 52-Week Range | $0.91 - $2.99 |
| Market Cap | $146.1M |
| P/E Ratio | -2.33 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 392,723 |
| Average Daily Volume | 664,073 |
| Current FY EPS | -$0.29 |
Sector
Healthcare
Industry
Drugs
Geron Corp (GERN) Description
A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website: http://www.geron.com/
News & Commentary
Only One of These Stocks Won't Be a Winner
These stocks just rolled over. Which ones will bounce back?GERN's Top Competitors
(0.00%)
(0.27%)
(0.59%)
(1.13%)